Monday, October, 19, 2009
Treatments For Schizophrenia
October 03, 2008
The U.S. Food and Drug Administration has approved Risperdal for
the treatment of schizophrenia and bipolar disorder in children and
teens. Risperdal is now the only approved med for the treatment of
schizophrenia in youths, and it joins lithium as an approved
treatment for teen bipolar disorder.
Read more »
Expert & Community Posts
By Jerry Kennard
,
Health Expert
One of the first targeted treatments for schizophrenia has been announced in this month's American...
Read more »
By Robin Cunningham
,
Health Expert
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar...
Read more »
By Paul Ballas
,
Health Expert
1. What types of reactions should be expected after an individual begins undergoing treatment for...
Read more »
By Paul Ballas
,
Health Expert
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the...
Read more »
By Teri Robert
,
Health Expert
Today, the FDA approved Risperdal for the treatment of schizophrenia in adolescents 13 to 17...
Read more »
Health Guide
In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first...
Read more »
...generally used for schizophrenia:Typical antipsychotics. Until recently, these drugs were the mainstay
treatments for schizophrenia. They include haloperidol (Haldol), chlorpromazine (Thorazine),...
Read more »
Other TreatmentsElectroconvulsive therapy (ECT), often called shock treatment, has received bad press since it was introduced in the 1940s. However, refined techniques have revived its use,...
Read more »
ReferencesAleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin...
Read more »
Schizophrenia affects over 2 million Americans. Although the causes are still unknown and a cure is not yet available, according to the National Institute of Mental Health this is a "time of...
Read more »
Related News
October 02, 2008
The Food and Drug Administration (FDA) has approved extended-release Invega for the treatment of schizophrenia. The FDA made the decision after...
Read summary »
October 02, 2008
Drugmaker AstraZeneca is seeking approval from the Food and Drug Administration for a once-daily formula of Seroquel. Seroquel is currently approved...
Read summary »
February 22, 2007
By Lucy Williams, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Some patients undergoing treatment for mental illness gain so...
Read summary »
September 19, 2008
A study suggests that immaturity in the areas of the brain that control memory and mood may lead to schizophrenia. In a study involving mice that...
Read summary »
August 10, 2009
An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and...
Read summary »